AMDD Fees and Costs — Direxion Daily AMD Bear 1X Shares

Data updated: 2026-09-28

The net expense ratio is 0.97% (0.99% before fee waivers). There are no sales loads or redemption fees. In fiscal 2025 the fund paid $10K in broker commissions, 0.1920% of average net assets.

AMDD Fees and Expenses

Annual operating expenses and sales charges of AMDD. Prospectus, as of February 28, 2025.

Annual operating expenses
Management fee0.75%
12b-1 fee0.00%
Other expenses0.22%
Gross expense ratio0.99%
Fee waiver−0.02%
Net expense ratio0.97%
Sales charges
Max front load—
Max deferred load—
Redemption fee—
Expense limitation in place (N-CEN)Yes
Fees waived or reduced during the yearYes
Waived fees subject to recoupmentYes

AMDD Costs Over Time

On $10,000 invested in AMDD, assuming 5% a year before costs, total costs come to $724 over 5 years, cutting the return by 1.22% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).

$10,000 investedSell after 1 yearSell after 3 yearsSell after 5 years
Value before costs$10,500$11,576$12,763
Fund expenses (net expense ratio 0.97%)$102$317$549
Trading costs (broker commissions)$20$63$109
Lost growth on money paid in costs$0$19$67
Total costs$122$399$724
Value after costs$10,378$11,177$12,038
Impact on return, per year1.22%1.22%1.22%

AMDD Trading Costs

Brokerage costs reported on SEC Form N-CEN for the fiscal year ending October 31, 2025.

  • Explicit cost rate (commissions ÷ average net assets): 0.1920%
  • Total broker commissions: $10K
  • Bought from dealers (principal trades, not a cost): —
  • Portfolio turnover (prospectus): —
  • Securities lending: none during the year

AMDD Agency Brokers

Commissions paid.

BrokerAmountShare
Citibank, National Association$4K39.80%
Barclays Bank PLC$3K27.11%
Bank of America N.A.$3K27.10%
Goldman Sachs & Co. LLC$5915.99%

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.